HALO News and Press, Halozyme Therapeutics Inc. From 01/08/24

2024-01-08 17:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-12-18 12:05:08 ET More on iShares Russell 1000 Growth ETF: IWF ETF: Be Cautious Of High Valuations Top stocks with earning stability and quality + overweight - MS Morgan Stanley: Dividend paying stocks > non-dividend paying stocks, since 2000 Seeking ...

2023-12-12 13:17:41 ET More on Johnson & Johnson Johnson & Johnson Vs. Pfizer: Better Pharma Stock? Stocks To Watch: Big Week On Tap For McDonald's, Shopify, GameStop, And Johnson & Johnson Johnson & Johnson: Sleep Well At Night With The Only AAA-Rate...

2023-12-12 09:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-11-28 06:45:51 ET More on Argenx, Halozyme, etc. argenx Q3: Navigating The Highs And Hurdles Of A Market Odyssey (Rating Upgrade) Halozyme Q3: Navigating The Ups And Downs Of Its Innovative Pathway Halozyme Therapeutics, Inc. (HALO) Q3 2023 Earnings Call Transcr...

2023-11-17 09:26:34 ET More on Teva Pharmaceutical Teva Pharmaceutical Industries Limited (TEVA) Q3 2023 Earnings Call Transcript Teva Pharmaceutical Industries Limited 2023 Q3 - Results - Earnings Call Presentation Teva: Focus On Innovation And Growth Means The Time...

Halozyme Announces argenx Receives European Commission Approval of VYVGART® SC with ENHANZE® for Generalized Myasthenia Gravis PR Newswire VYVGART® SC Now Approved for Subcutaneous Administration, Adding to the Already Approved IV Administration SAN DI...

2023-11-16 08:04:42 ET More on Argenx SE argenx SE (ARGX) Q3 2023 Earnings Call Transcript argenx: Efgartigimod Is Not Just A Drug, A Cornerstone Argenx SE GAAP EPS of -$1.25 beats by $0.18, total operating income of $339.84M beats by $38.12M Immunovant drive...

2023-11-15 20:26:43 ET Summary Halozyme's Q3 2023 earnings showed robust performance, with a 41% YoY increase in product sales and a 15% YoY growth in royalty revenue. The company's strategic moves, including a $250M share repurchase plan and new partnerships, highlight its commit...

2023-11-08 05:19:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Thanks to the biotechnology sector, the advances and improvement of processes within the health sector have been incredible. The impact with society and the contribution they make both directly...